CD22/CD19 CAR-T cell immunotherapy is named as a drug or biological intervention in 3 clinical trials in our China trial register, 2 of which are recruiting. Lead sponsors include Liping Dou (2) and Daihong Liu (1). Registered phase: Phase 2. Conditions studied include Lymphoma.
| NCT ID | Study | Phase | Status |
|---|---|---|---|
| NCT07587840 | CD19/CD22 CAR-T as First-line Consolidation in Follicular Lymphoma (ClinicalTrials.gov ↗) Lymphoma |
Phase 2 | Recruiting |
| NCT07779018 | CD19/CD22 CAR-T Consolidation in R/R Aggressive B-Cell Lymphoma After Second-Line Therapy (ClinicalTrials.gov ↗) Lymphoma |
Phase 2 | Recruiting |
| NCT07094477 | Study of Targeted CD22/CD19 CAR-T Therapy for First-line Consolidation of B-cell Lymphoma (ClinicalTrials.gov ↗) Lymphoma |
Phase 2 | Active, closed |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.
| Condition (as registered) | Trials |
|---|---|
| Lymphoma | 3 |
| Lead sponsor | Trials |
|---|---|
| Liping Dou | 2 |
| Daihong Liu | 1 |
| Register | CD22/CD19 CAR-T cell immunotherapy trials |
|---|---|
| Clinical trials in China | 3 |
A trial with sites in more than one country appears in each of those registers.
Everything on this page is copied from public ClinicalTrials.gov registry records — it is not written from memory, and nothing here describes how CD22/CD19 CAR-T cell immunotherapy works or whether it is effective. Each trial links to its own record so you can check it yourself.
This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists CD22/CD19 CAR-T cell immunotherapy (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 24 Sep 2026.